We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Research Suggests Avoidance of Low-Value Surgical Procedures

By HospiMedica International staff writers
Posted on 28 Nov 2017
A new study suggests that stopping just five high-cost general surgical procedures could reduce health services costs and improve patient care.

Researchers at Imperial College London (ICL; United Kingdom) conducted a study with the intention of identifying low-value interventions in general surgery, with a further assessment of their cost. More...
To do so, a multiplatform method that included a broad literature search, a targeted database search, and opportunistic sampling was established; the results were then stratified to assess both cost and frequency of each procedure. In all, 71 low value general surgical procedures were identified, of which five were of high volume and high cost, 23 were of high cost and low volume, 22 belonged to the low cost and high volume group, and 21 were in the low cost and low volume group.

The results revealed that the highest impact interventions included inguinal hernia repair in minimally symptomatic patients, inappropriate gastroscopy, interval cholecystectomy, computerized tomography (CT) scans to diagnose appendicitis, and a routine endoscopy performed in those with CT-confirmed diverticulitis. The five general surgical procedures carried a financial burden of €153 million. The study was published on November 8, 2017, in the British Journal of Surgery (BJS).

“It is the basic thought of every surgeon at their earliest decision when becoming a doctor to act in the patient’s best interests, and this inherent belief should provide motivation to maximize value of care,” said lead author Humza Malik, MD, of the ICL academic surgical unit. “Remembering this, clinicians should lead changes to provide pertinent, precise treatments, thereby avoiding ineffective interventions and challenging existing dogma that ‘more care is better care.’”

Since 2006, the National Institute for Health and Care Excellence (NICE; London, UK) has undertaken a formal agenda to address the issue of disinvesting in low-value care, procedures, and practices. Internationally, Choosing Wisely (Philadelphia, PA, USA) has also addressed the issue through promotion of physician and patient conversation, in order to reduce unnecessary interventions. The Choosing Wisely campaign has since been adopted by other countries, including Australia, Germany, Italy, Japan, the Netherlands, and Switzerland.

Related Links:
Imperial College London
National Institute for Health and Care Excellence
Choosing Wisely


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.